Cardiovascular disease in patients with COPD

Affiliations

¹ University of Rome Tor Vergata, Department of Systems Medicine, Chair of Respiratory Medicine, Rome, Italy; University of Rome Tor Vergata, Department of Systems Medicine, Respiratory Pharmacology Research Unit, Rome, Italy; University Hospital Policlinico Tor Vergata, Division of Respiratory Medicine, Rome, Italy. Electronic address: mario.cazzola@uniroma2.it.
² University of Rome Tor Vergata, Department of Systems Medicine, Chair of Respiratory Medicine, Rome, Italy; University Hospital Policlinico Tor Vergata, Division of Respiratory Medicine, Rome, Italy.
³ Second University of Naples, Department of Experimental Medicine, Unit of Pharmacology, Naples, Italy.

Comment

Mario Cazzola et al. Lancet Respir Med. 2015 Aug.

. 2015 Aug;3(8):593-5.

doi: 10.1016/S2213-2600(15)00279-9. Epub 2015 Jul 22.

¹ University of Rome Tor Vergata, Department of Systems Medicine, Chair of Respiratory Medicine, Rome, Italy; University of Rome Tor Vergata, Department of Systems Medicine, Respiratory Pharmacology Research Unit, Rome, Italy; University Hospital Policlinico Tor Vergata, Division of Respiratory Medicine, Rome, Italy. Electronic address: mario.cazzola@uniroma2.it.
² University of Rome Tor Vergata, Department of Systems Medicine, Chair of Respiratory Medicine, Rome, Italy; University Hospital Policlinico Tor Vergata, Division of Respiratory Medicine, Rome, Italy.
³ Second University of Naples, Department of Experimental Medicine, Unit of Pharmacology, Naples, Italy.

No abstract available

Comment on

Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Chen W, et al. Lancet Respir Med. 2015 Aug;3(8):631-9. doi: 10.1016/S2213-2600(15)00241-6. Epub 2015 Jul 22. Lancet Respir Med. 2015. PMID: 26208998